Hey mate, no, you haven't missed anything.
There was the slightest hint of it in the latest 4E as seen below.
But ever since JVDW came on board, his stewardship has refocused the company on progressing Remplir to market as a priority.
The other products such as the Collagen Rope and Lymphatic Vessel regeneration, while still in development, are on the back burner.
Personally, I like this approach. Let focus on Striate expansion and revenues and bring Remplir to market, all the while developing more Cellgro platforms in the background.
⁹
No guarantee on the below, but the potential is there for a lot of further development.
Lots in the pipeline, not just Rope.
Media thread, page-617
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
-0.015(2.34%) |
Mkt cap ! $149.4M | |||
| Open | High | Low | Value | Volume |
| 64.5¢ | 64.5¢ | 62.0¢ | $124.1K | 195.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12045 | 62.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 64.0¢ | 20258 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |